Goski is now pursuing claims under the Americans with Disabilities Act, the Family and Medical Leave Act, and the Age ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed.

The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties.

Abbott Laboratories must pay $495 million in damages in the case of a girl who developed a serious gastrointestinal disease as a premature infant after consuming Abbott formula, a Missouri jury ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Get the live share price of Abbott Laboratories (ABT), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Abbott Laboratories (NYSE:ABT) will release its quarterly earnings report on Wednesday, 2024-10-16. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Abbott ...

On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA ...

Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, ...

Abbott Laboratories (NYSE:ABT) reported better-than-expected first-quarter adjusted EPS results on Wednesday. Abbott Laboratories reported first-quarter sales of $10.36 billion, up 7.2% year over year ...